Seeking Cures For
All 16 of our Taubman Scholars are practicing physicians whose patients are an ever-present reminder of the urgent need for new cures and therapies. Their areas of expertise range from stroke and heart attack to ALS to the vision loss that is a common complication of diabetes.
A number of our scientists are seeking new treatments for a range of cancers – including a common childhood cancer – while others are working to understand conditions like obesity and skin diseases.
In just three short years, Taubman Scholars have published 94 articles in leading scientific journals, and Taubman Institute support has led to 10 human clinical trials of new treatments for disease.
To read more about how each Scholar’s approach targets specific diseases, click on the links to their research outline.
Amyotrophic lateral sclerosis (ALS)
Diabetes and complications of diabetes
Heart attack and stroke
Motor neuron disease
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.